BioSpace News Archive

Drug Development

Aptinyx Suffers Defeat in Diabetic Peripheral Neuropathy as Drug Fails Endpoint

Aptinyx therapeutic NYX-2925, intended to treat painful diabetic peripheral neuropathy failed to produce significant results. Here is why it happened.

April 7, 2022
·
2 min read
·
Hayley Shasteen
Drug Development

A Week After Anemia Drug Rejection, Akebia Lays Off 42% of Workforce

In a regulatory filing, the Cambridge, Massachusetts-based company indicated that it plans to “refocus its strategic priorities” and lay off 42% of its workforce.

April 7, 2022
·
2 min read
·
Mark Terry
Genetown

Medicare Officially Restricts Coverage of Biogen’s Aduhelm

Shares of Biogen are falling in post-market trading after the U.S. government officially announced it will limit coverage of the company’s controversial Alzheimer’s drug Aduhelm to patients in clinical trials.

April 7, 2022
·
3 min read
·
Alex Keown
Business

BioSpace Movers & Shakers, April 8

Onxeo, Amydis, eFFECTOR Therapeutics, Freenome, Urovant Sciences and others all added new guidance and perspectives to their C-suite this week.

April 7, 2022
·
10 min read
·
Alex Keown
Deals

Pfizer Bolsters RSV Position with $525 Million ReViral Buy

Pfizer is taking a deeper dive into infectious disease with the acquisition of North Carolina-based ReViral, a biotech focused on developing therapeutics that target respiratory syncytial virus (RSV).

April 7, 2022
·
3 min read
·
Alex Keown
Sunshine Biopharma’s Stock Scorches with Promising mRNA Molecules for Cancer

Sunshine Biopharma, Inc announced this week that its novel-formulation mRNA molecules induce cancer cell death in cell cultures.

April 7, 2022
·
2 min read
·
Jazmine Colatriano, M.S.
Drug Development

Moderna Expands Product Line, Global Efforts, with IAVI Partnership

Building on the success of its COVID-19 mRNA vaccine, Moderna, Inc. is partnering with the nonprofit scientific research organization IAVI to develop treatments and vaccines against global health threats.

April 7, 2022
·
2 min read
·
Mark Terry
Triana Raises $110M to Solve Undruggable Cancer Targets with Molecular Glue

Triana Biomedicines leaped out of stealth mode with $110 million in Series A financing that will be used to fund its mission to discover and develop novel small molecules to treat diseases.

April 7, 2022
·
2 min read
·
Alex Keown
Out of Office: a Comprehensive Guide to Vacation Days and PTO (Paid Time Off)

If your personal life has taken a backseat, it might be time to use your paid time off. Learn everything you need to know about PTO and how to request it in our guide.

April 7, 2022
·
5 min read
·
Franklin Carpenter
Policy

PureTech Health: Notice of Results

PureTech Health plc plans to publish its annual report and financial results on Tuesday, April 26, 2022 at 2:00 AM EDT / 7:00 AM BST.

April 7, 2022
·
3 min read